Wednesday, September 17, 2025
HomeIndustriesBiotechnology

Biotechnology

Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands

Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced  that ONTOZRY® (cenobamate) is now available in the Netherlands for...

Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia

Reata Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced the completion of the rolling submission of a New Drug Application (“NDA”) to the U.S. Food...

Paine Schwartz Completes Strategic Investment in Hendrix Genetics, a Leading Multi-Species Animal Genetics and Technology Company

Hendrix Genetics (the "Company"), a leading multi-species animal genetics and technology company and Paine Schwartz Partners, a global leader in sustainable food chain investing,...

Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to a Find Tailored Treatment for the Complex Rare Disease

Scenic Biotech BV ('Scenic' or 'the Company'), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for...

Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial

Cellphire Therapeutics, Inc., a biotechnology company developing next-generation pooled allogeneic cellular therapeutics for application across multiple medical indications, announced that the 1st patient has...
0FansLike
0FollowersFollow
spot_img

Hot Topics